MEDICINES CO [THE] MDCO (NASDAQ) $ 14.71 Change: -0.07 -0.48% | Volume: 501,325
Sponsored by Click here!

MEDICINES CO - Fundamental Profile

Company Information

Ticker Symbol: MDCO
Exchange: NASD
Contact Info: 8 Campus Drive Parsippany NJ 07054 973 656-1616
CEO/President: Clive A. Meanwell
Industry: Medical - Biomedical / Standard Industry Code: 2834
Description: Medicines Company acquires, develops and commercializes biopharmaceutical products in late stages of development. U.S. Food and Drug Administration intends to approve its first product, Angiomax, for use in the treatment ofpatients with unstable angina undergoing coronary balloon angioplasty. The company is also developing Angiomax for additional potential applications for use in the treatment of ischemic heart disease, a condition which occurs when organs receive an inadequate supply of oxygen as a result of decreased blood flow.

Share Information

Shares Outstanding: 52,080 (000) Market Value: 769,770 ($000)
Percentage of Inst.Shareholders: 95.06% Number of Inst.Shareholders: 4.70%
Last Quarter Sales: 88.13 ($Mil.) Last Quarter Net Income: -13.22 ($Mil.)
Last Quarter EPS: 0.00 P/E Ratio: 74
Most Recent Earnings: 0.05 on 10/22/08 Earnings Per Share: -0.05
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN INC. +9.10 56.09
GILEAD SCIENCES -1.80 45.91
CELGENE CORPORA -8.00 58.56
BIOGEN IDEC INC -31.90 43.13
STEMCELLS INC. -56.40 1.23